By staff writers

December 21, 2016 -- Medical statistics and data mining firm Statlife has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its DenSeeMammo breast density assessment software.

The software provides a standardized and automatic breast density evaluation according to BI-RADS guidelines and can be combined with Statlife's MammoRisk risk assessment tool, the company said. It is compatible with GE Healthcare's Senographe Essential mammography systems, according to Statlife.

If you like this content, please share it with a colleague!
Copyright © 2016

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Sign in using your social networking account:
Sign in using your social networking